Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Launch Excellence: The Path Forward for Medical Affairs
Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...
Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward
Ensuring that your organization embraces DE & I training is important for cultivating a strong...
Why Is It Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health
Making research and data reproducible is vital to improving public health and reinstating trust in...
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...